Jakob Eberhard
Overview
Explore the profile of Jakob Eberhard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1339
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bojesson A, Brun E, Eberhard J, Segerlantz M
Br J Cancer
. 2024 Jul;
131(4):729-736.
PMID: 38951699
Background: The primary aim of specialised palliative care (SPC) is to improve the quality of life (QoL) for patients with a high symptom burden from a life-threatening disease. This randomised...
2.
Nilbert M, Eberhard J, Engdahl Severin J, Edelhamre M, Torle F, Korkocic D, et al.
Acta Oncol
. 2024 Feb;
63:1-2.
PMID: 38421054
Corrigendum for article: DOI: 10.1080/0284186X.2023.2281005.
3.
Nilbert M, Eberhard J, Engdahl Severin J, Edelhamre M, Torle F, Korkocic D, et al.
Acta Oncol
. 2023 Nov;
62(12):1945-1951.
PMID: 37966970
No abstract available.
4.
Hau S, Svensson M, Petersson A, Eberhard J, Jirstrom K
BMC Cancer
. 2023 Nov;
23(1):1074.
PMID: 37936126
Background: There is still a profound lack of efficient therapeutic strategies against pancreatic and other periampullary adenocarcinoma. Surgery is seldom possible, leaving palliative chemotherapy the only option for most patients....
5.
Hau S, Williamsson C, Andersson B, Eberhard J, Jirstrom K
BMC Cancer
. 2023 Apr;
23(1):334.
PMID: 37041522
Background: Periampullary cancer is a term for cancers arising in or in close proximity to the pancreas. Pancreatic cancer is the 3 leading cause of cancer death for both sexes...
6.
Ekstrom A, Brun E, Eberhard J, Segerlantz M
J Pancreat Cancer
. 2022 Sep;
8(1):2-8.
PMID: 36092954
Introduction: The incidence of pancreatic cancer is around 5 in 100,000, and the 5-year survival is poor. Pancreatic cancer patients have a high disease-specific burden of symptoms, and palliative chemotherapy...
7.
Siesing C, Petersson A, Ulfarsdottir T, Chattopadhyay S, Nodin B, Eberhard J, et al.
Mod Pathol
. 2022 Feb;
35(7):979-988.
PMID: 35169225
In a non-negligible number of patients with metastatic colorectal cancer (mCRC), the peritoneum is the predominant site of dissemination. Cure can be achieved by cytoreductive surgery (CRS) and hyperthermic intraperitoneal...
8.
Petersson A, Andersson N, Hau S, Eberhard J, Karlsson J, Chattopadhyay S, et al.
Mol Cancer Res
. 2022 Feb;
20(5):749-761.
PMID: 35149544
Implications: Evolutionary copy-number patterns may be associated with survival in patients with resected PDAC.
9.
Ekedahl H, Isaksson S, Stahl O, Bogefors K, Romerius P, Eberhard J, et al.
BMC Cancer
. 2022 Feb;
22(1):157.
PMID: 35135482
Background: In childhood (CCS) and testicular cancer (TCS) survivors, low-grade inflammation may represent a link between testosterone deficiency (hypogonadism) and risk of metabolic syndrome. We aimed to study levels of...
10.
Falk P, Severin M, Berglund A, Guren M, Hofsli E, Osterlund P, et al.
Cancer Treat Res Commun
. 2022 Feb;
31:100517.
PMID: 35114500
Background: The incidence of colorectal cancer (CRC) in individuals of fertile age is increasing. Oxaliplatin is a cornerstone treatment in the adjuvant setting for stage III and high-risk stage II...